Klaus Viktor Toyka
#111,236
Most Influential Person Now
German neurologist
Klaus Viktor Toyka's AcademicInfluence.com Rankings
Klaus Viktor Toykamedical Degrees
Medical
#1506
World Rank
#1850
Historical Rank
Neurology
#130
World Rank
#196
Historical Rank

Download Badge
Medical
Why Is Klaus Viktor Toyka Influential?
(Suggest an Edit or Addition)Klaus Viktor Toyka's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome (1998) (849)
- Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. (1994) (731)
- Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. (1997) (648)
- Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters (2002) (558)
- Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome (1997) (542)
- Effect of a Novel Free Radical Scavenger, Edaravone (MCI-186), on Acute Brain Infarction (2003) (534)
- Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. (2005) (446)
- Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. (1977) (437)
- CNTF is a major protective factor in demyelinating CNS disease: A neurotrophic cytokine as modulator in neuroinflammation (2002) (400)
- Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice (1995) (369)
- Preceding infections, immune factors, and outcome in Guillain–Barré syndrome (2001) (369)
- Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice. (1996) (368)
- Axonal prion protein is required for peripheral myelin maintenance (2010) (362)
- Animal models for autoimmune demyelinating disorders of the nervous system. (2000) (315)
- Structural Abnormalities and Deficient Maintenance of Peripheral Nerve Myelin in Mice Lacking the Gap Junction Protein Connexin 32 (1997) (313)
- Protein zero (P0)–deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies (1995) (307)
- Immunopathogenesis and treatment of the guillain‐barré syndrome—part I (1995) (293)
- Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. (2004) (283)
- Differential expression of cytokines in painful and painless neuropathies (2007) (276)
- Substance P: binding properties and studies on cellular responses in guinea pig macrophages. (1986) (271)
- A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis (2000) (269)
- Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin. (1998) (241)
- Mice deficient for the glycoprotein show subtle abnormalities in myelin (1994) (237)
- Impaired Differentiation of Schwann Cells in Transgenic Mice with Increased PMP22 Gene Dosage (1996) (236)
- Specific Subtypes of Cutaneous Mechanoreceptors Require Neurotrophin-3 Following Peripheral Target Innervation (1996) (234)
- Inflammatory mediators in demyelinating disorders of the CNS and PNS (1992) (229)
- Autoimmune human T lymphocytes specific for acetylcholine receptor (1984) (224)
- Disease progression in amyotrophic lateral sclerosis: Predictors of survival (2002) (223)
- A PD‐1 polymorphism is associated with disease progression in multiple sclerosis (2005) (220)
- Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations (2008) (218)
- Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis (2005) (210)
- Production of nitrite by neonatal rat microglial cells/brain macrophages. (1992) (208)
- Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis (2000) (206)
- Myasthenia gravis (1983) (201)
- Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin (2005) (200)
- Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM‐1 (1993) (192)
- Microglia and macrophages are major sources of locally produced transforming growth factor‐β1 after transient middle cerebral artery occlusion in rats (1998) (191)
- Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy (2001) (190)
- Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood. (1997) (187)
- A role for BDNF in mechanosensation (1998) (187)
- Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy (1999) (186)
- Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis. (2003) (182)
- Activation of macrophages by substance P: induction of oxidative burst and thromboxane release. (1983) (182)
- Inflammatory infiltrates in sural nerve biopsies in Guillain‐Barré syndrome and chronic inflammatory demyelinating neuropathy (1996) (182)
- Etanercept reduces hyperalgesia in experimental painful neuropathy (2001) (181)
- The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain‐Barré syndrome and in other neuroimmunological disorders (1993) (178)
- Intravenous immunoglobulin for myasthenia gravis. (2003) (174)
- Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. (2010) (167)
- The Wlds Mutation Delays Robust Loss of Motor and Sensory Axons in a Genetic Model for Myelin-Related Axonopathy (2003) (164)
- Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-α, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin (2000) (159)
- Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: Correlation with magnetic resonance imaging (1995) (158)
- Serum interleukin‐2 concentrations in Guillain‐Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: Comparison with other neurological diseases of presumed immunopathogenesis (1991) (156)
- Heterozygous Peripheral Myelin Protein 22-Deficient Mice Are Affected by a Progressive Demyelinating Tomaculous Neuropathy (1997) (156)
- Cytokine mRNA expression in patients with multiple sclerosis and fatigue (2004) (156)
- Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy (2010) (152)
- Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. (2002) (151)
- Serial Determination of Tumor Necrosis Factor-Alpha Content in Rat Sciatic Nerve after Chronic Constriction Injury (1999) (148)
- Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies (2008) (148)
- The role of macrophages and eicosanoids in the pathogenesis of experimental allergic neuritis. Serial clinical, electrophysiological, biochemical and morphological observations. (1988) (148)
- Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis (1995) (147)
- Escalating immunotherapy of multiple sclerosis (1999) (146)
- Transforming growth factor-β1: A lesion-associated cytokine of the nervous system (1995) (143)
- Microglial Phagocytosis of Apoptotic Inflammatory T Cells Leads to Down-Regulation of Microglial Immune Activation1 (2001) (141)
- Symptomatic Treatment of Multiple Sclerosis (2006) (141)
- Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability (2001) (139)
- Different Intracellular Pathomechanisms Produce Diverse Myelin Protein Zero Neuropathies in Transgenic Mice (2006) (137)
- Corticosteroids for myasthenia gravis. (2005) (137)
- in Vivo Monitoring of Macrophage Infiltration in Experimental Ischemic Brain Lesions by Magnetic Resonance Imaging (2003) (135)
- Plasma exchange for myasthenia gravis. (2002) (133)
- Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders (2001) (132)
- Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis. (2006) (130)
- High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes. (2001) (127)
- Intravenous immunoglobulin for myasthenia gravis. (2012) (127)
- Assessing grip strength in healthy individuals and patients with immune‐mediated polyneuropathies (2000) (121)
- Neuromuscular blockade by IgG antibodies from patients with Guillain‐Barré syndrome: A macro‐patch‐clamp study (1998) (120)
- HLA-DQ BETA-CHAIN POLYMORPHISM LINKED TO MYASTHENIA GRAVIS (1986) (120)
- Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS‐1) (2007) (119)
- Plasma exchange for generalised myasthenia gravis (2002) (119)
- Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance. (2000) (118)
- T cell activation in Guillain‐Barré syndrome and in MS (1990) (118)
- T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy. (2000) (117)
- Intravenous immunoglobulins neutralize blocking antibodies in Guillain‐Barré syndrome (2002) (117)
- Patients with active relapsing‐remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: Implications for remyelination (2000) (116)
- Motor neuropathy in porphobilinogen deaminase-deficient mice imitates the peripheral neuropathy of human acute porphyria. (1999) (115)
- Production and characterization of monoclonal antibodies to the extracellular domain of P0 (1993) (115)
- Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene. (2002) (114)
- Treatment of gustatory sweating with botulinum toxin (1997) (112)
- Fatigue in MS is related to sympathetic vasomotor dysfunction (2003) (112)
- The Role of Macrophages in Demyelinating Peripheral Nervous System of Mice Heterozygously Deficient in P0 (2001) (111)
- Circulating adhesion molecules and inflammatory mediators in demyelination (1995) (111)
- Azathioprine toxicity during long‐term immunosuppression of generalized myasthenia gravis (1988) (110)
- Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography (1996) (110)
- Phagocytosis of apoptotic inflammatory cells by microglia and its therapeutic implications: Termination of CNS autoimmune inflammation and modulation by interferon‐beta (2003) (110)
- The role of interferon‐gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system (1990) (109)
- Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP (2005) (108)
- Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide— mechanisms independent of pyrimidine depletion (2004) (107)
- H2O2 and Nitric Oxide‐mediated Oxidative Stress Induce Apoptosis in Rat Skeletal Muscle Myoblasts (1996) (107)
- Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis (2006) (106)
- In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema. (1996) (105)
- Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis. (2015) (103)
- Autonomic dysfunction in ALS: A preliminary study on the effects of intrathecal BDNF (2005) (102)
- Substance P and astrocytes: stimulation of the cyclooxygenase pathway of arachidonic acid metabolism (1988) (102)
- Expression of specific matrix metalloproteinases in inflammatory myopathies. (2001) (101)
- Myasthenia gravis: Reactivation of clinical disease and of automimmune factors after discontinuation of long‐term azathioprine (1985) (101)
- Cytokine-induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule-1. (2000) (100)
- Outcome in juvenile-onset myasthenia gravis: a retrospective study with long-term follow-up of 79 patients (1997) (100)
- Fatal PML associated with efalizumab therapy (2012) (98)
- Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients (2005) (98)
- PREDNISONE IN DUCHENNE MUSCULAR DYSTROPHY (1974) (98)
- Association of a null mutation in the CNTF gene with early onset of multiple sclerosis. (2002) (96)
- Multiple symmetric lipomatosis (1994) (96)
- Conduction failure and nerve conduction slowing in experimental allergic neuritis induced by P2‐specific T‐cell lines (1986) (96)
- Failure of anti‐GM1 IgG OR IgM to induce conduction block following intraneural transfer (1995) (96)
- Pravastatin-associated inflammatory myopathy. (1992) (95)
- Human T-helper lymphocytes in myasthenia gravis recognize the nicotinic receptor alpha subunit. (1987) (95)
- Pre‐ and postsynaptic blockade of neuromuscular transmission by Miller–Fisher syndrome IgG at mouse motor nerve terminals (1998) (94)
- Astrocytes Are Less Efficient in the Removal of Apoptotic Lymphocytes than Microglia Cells: Implications for the Role of Glial Cells in the Inflamed Central Nervous System (2002) (94)
- Functional Connectivity under Optogenetic Control Allows Modeling of Human Neuromuscular Disease. (2016) (93)
- Myopathy as a first symptom of Huntington's disease in a Marathon runner (2007) (91)
- Botulinum toxin for palmar hyperhidrosis (1997) (91)
- Muscle pathology in 57 patients with myotonic dystrophy type 2 (2004) (89)
- Antigen presentation by astrocytes primes rat T-lymphocytes for apoptotic cell death (1994) (89)
- Suppression of experimental autoimmune neuritis by the oxygen radical scavengers superoxide dismutase and catalase (1988) (89)
- Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1. (2003) (87)
- Nerve growth factor evokes hyperalgesia in mice lacking the low-affinity neurotrophin receptor p75 (1998) (85)
- Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis. (2006) (85)
- Heparin and Air Filters Reduce Embolic Events Caused by Intra-Arterial Cerebral Angiography: A Prospective, Randomized Trial (2004) (84)
- Linkage of proximal myotonic myopathy to chromosome 3q (1999) (83)
- Soluble ICAM‐1 serum levels in multiple sclerosis and viral encephalitis (1993) (81)
- Pharmacokinetics of Intrathecally Applied BDNF and Effects on Spinal Motoneurons (1996) (79)
- Recombinant interleukin-1β stimulates eicosanoid production in rat primary culture astrocytes (1989) (77)
- A metalloprotease-inhibitor reduces pain associated behavior in mice with experimental neuropathy 1 Presented in part at the Meeting of the Peripheral Nerve Society, Cambridge, UK, July 10, 1997. 1 (1997) (77)
- Presence of the terminal complement complex (C5b‐9) precedes myelin degradation in immune‐mediated demyelination of the rat peripheral nervous system (1991) (76)
- Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients (2004) (76)
- Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats (2013) (76)
- Cognitive performance after coronary artery bypass grafting: A follow-up study (2002) (76)
- Synergistic Effect of IFN-γ and TNF-α on Expression of Immune Molecules and Antigen Presentation by Schwann Cells (1995) (75)
- Sequential expression of chemokines in experimental autoimmune neuritis (2000) (75)
- Myeloma neuropathy: passive transfer from man to mouse. (1981) (75)
- Production of MMPs in Human Cerebral Endothelial Cells and Their Role in Shedding Adhesion Molecules (2001) (74)
- MHC Class l‐Mediated Cytotoxicity Does Not Induce Apoptosis in Muscle Fibers nor in Inflammatory T Cells: Studies in Patients with Polymyositis, Dermatomyositis, and Inclusion Body Myositis (1996) (73)
- Escalating immunotherapy of multiple sclerosis--new aspects and practical application. (2004) (73)
- Neuropathology and binding studies in anti-amphiphysin-associated stiff-person syndrome (2003) (73)
- Immune Mechanisms in Inflammatory Polyneuropathy a (1988) (72)
- Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Implications for the pathogenesis of myasthenia gravis. (1996) (72)
- Guillain‐barré syndrome (1987) (71)
- Rapid-onset central motor plasticity in multiple sclerosis (2010) (71)
- Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies (2003) (70)
- An animal model for Charcot-Marie-Tooth disease type 4B1. (2005) (70)
- Selective elimination of macrophages by dichlormethylene diphosphonate-containing liposomes suppresses experimental autoimmune neuritis (1993) (70)
- Immunopathogenesis and treatment of the guillain–barré syndrome—part II (1995) (69)
- Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases. (1999) (68)
- Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome (2000) (68)
- Induction of IL-10 in rat peritoneal macrophages and dendritic cells by glatiramer acetate (2004) (68)
- Quantification of interleukin-6 mRNA in wallerian degeneration by compétitive reverse transcription polymerase chain reaction (1996) (68)
- Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice (1995) (68)
- ["Fatigue" in multiple sclerosis. Development and and validation of the "Würzburger Fatigue Inventory for MS"]. (2006) (67)
- Suppression of experimental autoimmune neuritis by leflunomide. (2001) (67)
- Kinetics and Organ Distribution of IL-17-Producing CD4 Cells in Proteolipid Protein 139–151 Peptide-Induced Experimental Autoimmune Encephalomyelitis of SJL Mice1 (2007) (66)
- Prevention and therapy of experimental autoimmune neuritis by an antibody against T cell receptors-alpha/beta. (1992) (66)
- Pyridostigmine but not 3,4‐diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle‐specific kinase autoantibody (2013) (66)
- Neurological multisystem manifestation in multiple symmetric lipomatosis: A clinical and electrophysiological study (1995) (66)
- Activated T cells of nonneural specificity open the blood‐nerve barrier to circulating antibody (1995) (66)
- Isolation and characterization of an oligodendrocyte precursor–derived B‐cell epitope in multiple sclerosis (1998) (65)
- Preventive but not therapeutic application of Rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats (1996) (65)
- Myasthenia gravis (1986) (63)
- The Gdap1 knockout mouse mechanistically links redox control to Charcot–Marie–Tooth disease (2014) (62)
- Amphipathic segment of the nicotinic receptor alpha subunit contains epitopes recognized by T lymphocytes in myasthenia gravis. (1988) (62)
- Suppression of experimental allergic neuritis by an antibody to the intracellular adhesion molecule ICAM-1. (1993) (62)
- Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies. (1998) (62)
- Comparison of maximal voluntary isometric contraction and Drachman's hand‐held dynamometry in evaluating patients with amyotrophic lateral sclerosis (1999) (61)
- Mtmr13/Sbf2-deficient mice: an animal model for CMT4B2. (2007) (61)
- Mycophenolate mofetil in the therapy of polymyositis associated with a polyautoimmune syndrome (2002) (61)
- Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis. (1985) (60)
- Myelin is dependent on the Charcot–Marie–Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cells (2012) (60)
- EAE in beta-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses (2005) (60)
- Neurology's witness to history (1998) (59)
- Intravenous Glucocorticosteroid Treatment Augments Apoptosis of Inflammatory T Cells in Experimental Autoimmune Neuritis (EAN) of the Lewis Rat (1995) (58)
- Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system. (1999) (58)
- The role of the very late antigen-4 and its counterligand vascular cell adhesion molecule-1 in the pathogenesis of experimental autoimmune neuritis of the Lewis rat. (1998) (57)
- Leukotriene production by cultured astroglial cells (1987) (57)
- Soluble complement receptor type 1 inhibits experimental autoimmune neuritis in Lewis rats (1995) (57)
- Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIDP (2003) (57)
- Phagocytotic removal of apoptotic, inflammatory lymphocytes in the central nervous system by microglia and its functional implications (2002) (57)
- Secretion of nitrite by Schwann cells and its effect on T-cell activation in vitro. (1996) (57)
- Early natural course of transient encephalopathy after coronary artery bypass grafting (2000) (55)
- "Atraumatic" Sprotte needle reduces the incidence of post-lumbar puncture headaches. (2002) (55)
- Effects of Natalizumab Treatment on Foxp3+ T Regulatory Cells (2008) (54)
- Human Stiff-Person Syndrome IgG Induces Anxious Behavior in Rats (2011) (54)
- Immunotherapy in autoimmune neuromuscular disorders (2003) (54)
- In vivo monitoring of macrophage infiltration in experimental autoimmune neuritis by magnetic resonance imaging (2004) (54)
- Transforming growth factor-beta 1 in experimental autoimmune neuritis. Cellular localization and time course. (1996) (54)
- Chronic inflammatory polyneuropathy Reduction of nerve conduction velocities in monkeys by systemic passive transfer of immunoglobulin G (1984) (54)
- T-cell receptor (TCR) usage in Lewis rat experimental autoimmune encephalomyelitis: TCR beta-chain-variable-region V beta 8.2-positive T cells are not essential for induction and course of disease. (1995) (53)
- Human autoantibodies to amphiphysin induce defective presynaptic vesicle dynamics and composition. (2016) (53)
- Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study. (2008) (53)
- Phorbol diester TPA elicits prostaglandin E release from cultured rat astrocytes (1987) (53)
- Sequential Expression of Transforming Growth Factor‐β1 by T‐cells, Macrophages, and Microglia in Rat Spinal Cord during Autoimmune Inflammation (1998) (52)
- Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies (2000) (52)
- Macrophages but not schwann cells express ia antigen in experimental autoimmune neuritis (1990) (51)
- Mitochondrial dysfunction with myoclonus epilepsy and ragged‐red fibers point mutation in nerve, muscle, and adipose tissue of a patient with multiple isymmetric lipomatosis (1997) (51)
- Molecular Mechanisms of High-Dose Antigen Therapy in Experimental Autoimmune Encephalomyelitis: Rapid Induction of Th1-Type Cytokines and Inducible Nitric Oxide Synthase1 (2000) (51)
- Mycophenolate Mofetil in the Therapy of Severe Myasthenia gravis (2001) (51)
- Genetic variation at position –1082 of the interleukin 10 (IL10) promotor and the outcome of multiple sclerosis (2000) (51)
- An Imbalance of Two Functionally and Phenotypically Different Subsets of Plasmacytoid Dendritic Cells Characterizes the Dysfunctional Immune Regulation in Multiple Sclerosis (2010) (51)
- Plasma exchange in chronic inflammatory polyneuropathy: Evidence suggestive of a pathogenic humoral factor (1982) (51)
- Skin biopsy as an additional diagnostic tool in non-systemic vasculitic neuropathy (2010) (50)
- The mouse blood-brain barrier and blood-nerve barrier for IgG: A tracer study by use of the avidin-biotin system (2004) (50)
- Anti-ganglioside antibodies alter presynaptic release and calcium influx (2007) (50)
- Blockade of signaling via the very late antigen (VLA-4) and its counterligand vascular cell adhesion molecule-1 (VCAM-1) causes increased T cell apoptosis in experimental autoimmune neuritis (2002) (50)
- Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors (2012) (49)
- The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model (2015) (49)
- Comparison of transcranial sonography, magnetic resonance imaging, and single photon emission computed tomography findings in idiopathic spasmodic torticollis (1997) (49)
- Selective loss of cholinergic sudomotor fibers causes anhidrosis in Ross syndrome (2002) (48)
- Transgenic Lewis rats overexpressing the proteolipid protein gene: myelin degeneration and its effect on T cell-mediated experimental autoimmune encephalomyelitis (1999) (48)
- Macrophages and endothelial cells express intercellular adhesion molecule-1 in immune-mediated demyelination but not in Wallerian degeneration of the rat peripheral nervous system. (1993) (48)
- Modulation of cytokine mRNA expression by brain-derived neurotrophic factor and nerve growth factor in human immune cells (2003) (47)
- In situ detection of transforming growth factor-β mRNA in experimental rat glioma and reactive glial cells (1994) (47)
- Psychotic Symptoms and Emotional Distress in Patients with Guillain-Barré Syndrome (2002) (47)
- The pathogenesis of CIDP (2003) (47)
- Magnetic resonance imaging investigation of blood-brain barrier damage in adoptive transfer experimental autoimmune encephalomyelitis (1993) (47)
- Non-neural-specific T lymphocytes can orchestrate inflammatory peripheral neuropathy. (1995) (47)
- Humoral factors in peripheral nerve disease (1987) (46)
- „Fatigue“ bei Multipler Sklerose (2006) (46)
- Progressive sudomotor dysfunction in amyotrophic lateral sclerosis (2002) (44)
- Spatial diversity of blood–brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: A comparative MRI study (2009) (44)
- Partial inhibition of AT-EAE by an antibody to ICAM-1: Clinico-histological and MRI studies (1996) (44)
- Proximal myotonic myopathy (2000) (43)
- Antigen therapy eliminates T cell inflammation by apoptosis: effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2. (1997) (43)
- The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis (2004) (43)
- Immune mechanisms in acquired demyelinating neuropathies: lessons from animal models (2002) (43)
- In situ demonstration of T cell activation and elimination in the peripheral nervous system during experimental autoimmune neuritis in the Lewis rat (1996) (43)
- Immunoadsorption versus plasma exchange versus combination for treatment of myasthenic deterioration (2016) (42)
- Human cerebral endothelial cells are a potential source for bioactive BDNF. (2002) (42)
- Production of prostanoids by Lewis rat Schwann cells in vitro (1994) (42)
- Diagnostic impact of cerebral transit time in the identification of microangiopathy in dementia: A transcranial ultrasound study. (1999) (42)
- LONG‐TERM CORRELATION OF CLINICAL COURSE AND ACETYLCHOLINE RECEPTOR ANTIBODY IN PATIENTS WITH MYASTHENIA GRAVIS (1981) (42)
- Malignancies after mitoxantrone for multiple sclerosis (2016) (41)
- THE PROPERTIES OF UNMYELINATED NOCICEPTIVE AFFERENTS CHANGE IN A PAINFUL CHRONIC CONSTRICTION NEUROPATHY (1994) (41)
- Depletion of neutralising antibodies resensitises a secondary non-responder to botulinum A neurotoxin (1998) (40)
- Primary rat astroglial cultures can generate leukotriene B4 (1988) (40)
- Influenza vaccination in MS (2001) (40)
- Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1. (1994) (39)
- Non-systemic vasculitic neuropathy: single-center follow-up of 60 patients (2015) (39)
- Gene polymorphism at position –308 of the tumor necrosis factor α promotor is not associated with disease progression in multiple sclerosis patients (1999) (38)
- Intrathecal, Polyspecific Antiviral Immune Response in Oligoclonal Band Negative Multiple Sclerosis (2012) (38)
- Protective role of the cytokine‐inducible isoform of nitric oxide synthase induction and nitrosative stress in experimental autoimmune encephalomyelitis of the DA rat (2003) (38)
- Relation of clinical, serological, morphological, and electrophysiological findings in galactocerebroside-induced experimental allergic neuritis. (1986) (38)
- Isolated meningeal tuberculoma mimicking meningioma: case report. (1995) (38)
- Potential role of LIF as a modifier gene in the pathogenesis of amyotrophic lateral sclerosis (2000) (38)
- Passive transfer studies in demyelinating neuropathy with IgM monoclonal antibodies to myelin-associated glycoprotein. (1985) (38)
- Lipocortin-1 (annexin-1) suppresses activation of autoimmune T cell lines in the Lewis rat (1996) (37)
- Serial analysis of cytokine mRNA profiles in whole blood samples from patients with early multiple sclerosis (2002) (37)
- Substance P, the immune system and inflammation. (1989) (37)
- Schwann cell apoptosis in experimental autoimmune neuritis of the Lewis rat and the functional role of tumor necrosis factor-α (2001) (37)
- Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2 (1995) (36)
- Atraumatic needle reduces the incidence of post-lumbar puncture syndrome (1994) (36)
- [Cellular immunity in inflammatory autoimmune neuropathies] (2002) (36)
- Neuroprotective effect of the immune system in a mouse model of severe dysmyelinating hereditary neuropathy: enhanced axonal degeneration following disruption of the RAG-1 gene (2005) (36)
- [Immunomodulatory staged therapy of multiple sclerosis. New aspects and practical applications, March 2002]. (2002) (35)
- Human IgG directed against amphiphysin induces anxiety behavior in a rat model after intrathecal passive transfer (2012) (35)
- Chronic inflammatory polyneuritis and related neuropathies (1996) (34)
- The PLPp-specific T-cell population promoted by pertussis toxin is characterized by high frequencies of IL-17-producing cells. (2007) (34)
- Modulation of experimental autoimmune neuritis in Lewis rats by oral application of myelin antigens (1997) (34)
- The PTPN22gain-of-function+1858T(+) genotypes correlate with low IL-2 expression in thymomas and predispose to myasthenia gravis (2009) (34)
- Polyethylene glycol-coupled IGF1 delays motor function defects in a mouse model of spinal muscular atrophy with respiratory distress type 1. (2014) (33)
- Increased autophagy in peripheral nerves may protect Wistar Ottawa Karlsburg W rats against neuropathy (2013) (33)
- Review: Progress in the treatment of myasthenia gravis (2008) (33)
- Apoptotic cell death of T-lymphocytes in experimental autoimmune neuritis of the Lewis rat (1994) (32)
- Hereditary defect of cobalamin metabolism (homocystinuria and methylmalonic aciduria) of juvenile onset. (1996) (32)
- Tumor necrosis factor-α (TNF) regulates the expression of ICAM-1 predominantly through TNF receptor 1 after chronic constriction injury of mouse sciatic nerve (2002) (32)
- Ultrastructural findings in endomyocardial biopsy of patients with Kearns-Sayre syndrome. (1988) (32)
- Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG. (1980) (32)
- Rat astrocytes express interferon-γ immunoreactivity in normal optic nerve and after nerve transection (1990) (31)
- Experimental autoimmune encephalomyelitis in mice with a targeted deletion of the inducible nitric oxide synthase gene: increased T-helper 1 response (2004) (31)
- Synergistic effect of IFN-gamma and TNF-alpha on expression of immune molecules and antigen presentation by Schwann cells. (1995) (31)
- Immune mechanisms in inflammatory polyneuropathy (1987) (30)
- Altered innate immune response of plasmacytoid dendritic cells in multiple sclerosis (2009) (30)
- Effector mechanisms in myasthenia gravis: End‐plate function after passive transfer of IgG, Fab, and F(ab′)2 hybrid molecules (1986) (30)
- Pathogenetic Significance of Fetal-Type Acetylcholine Receptors on Thymic Myoid Cells in Myasthenia Gravis (1992) (30)
- Bone Marrow Transfer from Wild-Type Mice Reverts the Beneficial Effect of Genetically Mediated Immune Deficiency in Myelin Mutants (2001) (30)
- Detection and quantification of antibodies to the extracellular domain of P0 during experimental allergic neuritis (1993) (29)
- Meningeal Hyperperfusion Visualized by MRI in a Patient With Visual Hallucinations and Migraine (1996) (29)
- Inherited demyelinating neuropathies: from gene to disease. (1998) (29)
- Downregulation of Transforming Growth Factor-&bgr;2 Facilitates Inflammation in the Central Nervous System by Reciprocal Astrocyte/Microglia Interactions (2007) (29)
- Clinical outcome of sural nerve biopsy: a retrospective study (1999) (29)
- IgG from patients with Guillain–Barré syndrome interact with nicotinic acetylcholine receptor channels (2003) (28)
- Functional role of ipsilateral motor areas in multiple sclerosis (2010) (28)
- Serum levels of soluble E‐selectin (ELAM‐1) in immune‐mediated neuropathies (1994) (27)
- Role of TNF‐α in High‐Dose Antigen Therapy in Experimental Autoimmune Neuritis: Inhibition of TNF‐α by Neutralizing Antibodies Reduces T‐Cell Apoptosis and Prevents Liver Necrosis (2000) (27)
- Creatine monohydrate in DM2/PROMM (2003) (27)
- Myasthenia gravis: further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model. (1978) (27)
- Regulation of Fas and FasL expression on rat Schwann cells. (2000) (26)
- Neuromyotonia in mice with hereditary myelinopathies (2000) (26)
- Expression of intercellular adhesion molecule-1 on rat microglial cells (1993) (26)
- Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN. (1994) (25)
- Plasma exchange in polyradiculoneuropathy (1980) (25)
- Mafosfamide induces DNA fragmentation and apoptosis in human T-lymphocytes. A possible mechanism of its immunosuppressive action. (1995) (25)
- Electrophysiological investigations in adoptively transferred experimental autoimmune encephalomyelitis in the Lewis rat. (1989) (25)
- Management of cervical radiculopathy. (1995) (25)
- Biphasic form of experimental autoimmune neuritis in dark agouti rats and its oral therapy by antigen‐specific tolerization (2004) (25)
- Assessment of cardiovascular autonomic function in myotonic dystrophy type 2 (DM2/PROMM) (2003) (25)
- T cell vaccination does not induce resistance to experimental autoimmune neuritis (1991) (25)
- Impact of the Asp299Gly polymorphism in the toll-like receptor 4 (tlr-4) gene on disease course of multiple sclerosis (2005) (24)
- Autoimmune responses in peripheral nerve (2004) (24)
- Escalating immunotherapy of multiple sclerosis.Austrian-German- Swiss Multiple Sclerosis Therapy Consensus Group [MSTCG]. (1999) (24)
- Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy (2015) (24)
- Neonatal Guillain-Barré syndrome (1999) (24)
- Ciclosporin A prevents P2 T cell line-mediated experimental autoimmune neuritis (AT-EAN) in rat (1987) (23)
- Vaccination, prevention, and treatment of experimental autoimmune neuritis (EAN) by an oligomerized T cell epitope (2001) (23)
- Failure of intravenous immunoglobulin (IVIg) therapy in experimental autoimmune neuritis (EAN) of the Lewis rat (1997) (23)
- Propentofylline and iloprost suppress the production of TNF-alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats. (1997) (23)
- Stiff person syndrome associated anti-amphiphysin antibodies reduce GABA associated [Ca2+]i rise in embryonic motoneurons (2009) (23)
- Cardiac metabolism and function in patients with multiple sclerosis: a combined 31P-MR-spectroscopy and MRI study. (2001) (22)
- Defective synaptic transmission causes disease signs in a mouse model of juvenile neuronal ceroid lipofuscinosis (2017) (22)
- Differential blocking effects of the monoclonal anti-GQ1b IgM antibody and alpha-latrotoxin in the absence of complement at the mouse neuromuscular junction (2002) (22)
- Eighty three years of the Guillain-Barré syndrome: clinical and immunopathologic aspects, current and future treatments. (1999) (22)
- Suppression of P2- T cell line-mediated experimental autoimmune neuritis by interleukin-2 receptor targeted monoclonal antibody ART 18 (1989) (21)
- Cerebral abscess in children secondary to esophageal dilatation. (1977) (21)
- [Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis]. (2008) (21)
- T cell directed immunotherapy of inflammatory demyelination in the peripheral nervous system. Potent suppression of the effector phase of experimental autoimmune neuritis by anti-CD2 antibodies. (1996) (20)
- Schwann cells, but not Oligodendrocytes, Depend Strictly on Dynamin 2 Function (2019) (20)
- Treatment of severe myasthenia gravis with protein A immunoadsorption and cyclophosphamide. (1997) (20)
- Excitability decreasing central motor plasticity is retained in multiple sclerosis patients (2012) (20)
- Impaired salivary gland function reveals autonomic dysfunction in amyotrophic lateral sclerosis (2002) (20)
- Diagnostic value of sural nerve biopsy in patients with suspected Borrelia neuropathy (2008) (20)
- Tor1a+/- mice develop dystonia-like movements via a striatal dopaminergic dysregulation triggered by peripheral nerve injury (2016) (20)
- Characterization of early immunological responses in primary cultures of differentially activated human peripheral mononuclear cells. (2001) (20)
- Effects of ganglioside administration on experimental autoimmune neuritis induced by peripheral nerve myelin or P2-specific T cell lines (1993) (20)
- Histocompatibility antigens and chemical reactivity in autoimmunity. (1987) (20)
- Cellular infiltrates in skin and sural nerve of patients with polyneuropathies (2017) (19)
- IL-17 production by thymocytes upon CD3 stimulation and costimulation with microbial factors. (2006) (19)
- CD8+ T cell help is required for efficient induction of EAE in Lewis rats (2013) (19)
- Interferon-beta antibodies: implications for the treatment of MS (2003) (19)
- Potential implications of a ciliary neurotrophic factor gene mutation in a german population of patients with motor neuron disease (1998) (19)
- [Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters]. (2008) (19)
- Magnetic resonance image findings of spinal intramedullary abscess caused by Candida albicans: case report. (1995) (18)
- Reversible conduction block in human ischemic neuropathy after ergotamine abuse (1992) (18)
- Vasculitis-like neuropathy in amyotrophic lateral sclerosis unresponsive to treatment (2011) (18)
- Serum antibodies to conformational and linear epitopes of myelin oligodendrocyte glycoprotein are not elevated in the preclinical phase of multiple sclerosis (2010) (18)
- Comparative analysis of motoneuron loss and functional deficits in PMN mice: implications for human motoneuron disease (1999) (18)
- Nerve biopsy in chronic inflammatory neuropathies: in situ biomarkers (2011) (18)
- Hereditary neuromyotonia: a mouse model associated with deficiency or increased gene dosage of the PMP22 gene (1997) (18)
- Inhibition of brain macrophage/microglial respiratory chain enzyme activity in experimental autoimmune encephalomyelitis of the Lewis rat (1995) (18)
- Influenza vaccination in MS: Absence of T-cell response against white matter proteins (2001) (18)
- [Cardiac arrhythmias in Guillain-Barre syndrome. An overview of the diagnosis of a rare but potentially life-threatening complication]. (2001) (18)
- The Role of Iron and Nerve Inflammation in Diabetes Mellitus Type 2-Induced Peripheral Neuropathy (2019) (17)
- Effects of intravenous immunoglobulins on T cell and oligodendrocyte apoptosis in high-dose antigen therapy in experimental autoimmune encephalomyelitis (2002) (17)
- [Glucocorticosteroid therapy in optic neuritis and multiple sclerosis. Evidence from clinical studies and practical recommendations]. (2001) (17)
- Reduced Rate of Microembolism by Optimized Aortic Cannula Position Does Not Influence Early Postoperative Cognitive Performance in CABG Patients (2003) (17)
- Regulation of Fas and FasL expression on rat Schwann cells (2000) (17)
- Rescue therapy with anti-CD20 treatment in neuroimmunologic breakthrough disease (2007) (17)
- Autoimmunity and inflammation in the peripheral nervous system (2002) (16)
- Adult-onset mixed myopathy with nemaline rods, minicores, and central cores: a muscle disorder mimicking polymyositis (2004) (16)
- T-cell apoptosis in inflammatory neuromuscular disorders associated with human immunodeficiency virus infection. (1999) (16)
- [Acetylcholine receptor antibodies in the diagnosis of myasthenia gravis. Study of 406 confirmed cases]. (2008) (16)
- Tuftsin stimulates the release of oxygen radicals and thromboxane from macrophages. (1983) (16)
- Inclusion body myositis in twins. (1999) (16)
- Effects of isoflurane anesthesia on F‐waves in the sciatic nerve of the adult rat (2014) (15)
- Music, motor control and the brain (2006) (15)
- Effects of mast cell degranulation on blood-nerve barrier permeability and nerve conduction in vivo (1994) (15)
- Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in patients with multiple sclerosis. (2004) (15)
- Guillain-Barré syndrome and CIDP (1994) (15)
- Proof of genetic heterogeneity in the proximal myotonic myopathy syndrome (PROMM) and its relationship to myotonic dystrophy type 2 (DM2) (2000) (15)
- Inflammatory Mechanisms in the Pathophysiology of Diabetic Peripheral Neuropathy (DN)—New Aspects (2021) (15)
- Tolerance Induction by Intrathymic Expression of P01 (2004) (15)
- Localization of interferon-gamma and Ia-antigen in T cell line-mediated experimental autoimmune encephalomyelitis. (1993) (15)
- Effects of myasthenic immunoglobulins and of prednisolone on spontaneous miniature end-plate potentials in mouse diaphragms (1979) (15)
- Experimental autoimmune myositis in the Lewis rat: lack of spontaneous T-cell apoptosis and therapeutic response to glucocorticosteroid application (2000) (15)
- Modulation of EAE by vaccination with T cell receptor peptides: Vβ8 T cell receptor peptide-specific CD4+ lymphocytes lack direct immunoregulatory activity (1993) (14)
- The role of nerve inflammation and exogenous iron load in experimental peripheral diabetic neuropathy (PDN) (2016) (14)
- Expression of integrins in experimental autoimmune neuritis and Guillain-Barre syndrome (1998) (14)
- Vav1-deficient mice are resistant to MOG-induced experimental autoimmune encephalomyelitis due to impaired antigen priming (2003) (14)
- Good recovery after sublethal ethylene glycol intoxication: serial EEG and CT findings (1989) (14)
- Tenth Meeting of the European Neurological Society 18–22 June, 2000, Jerusalem, Israël (2000) (14)
- Stiff person-syndrome IgG affects presynaptic GABAergic release mechanisms (2015) (13)
- Strategies for the modulation of neuroimmunological disease at the level of autoreactive T-lymphocytes (1985) (13)
- Miller Fisher syndrome: immunofluorescence and immunoelectron microscopic localization of IgG at the mouse neuromuscular junction (2001) (13)
- Multifocal motor neuropathy presenting as chronic progressive proximal leg weakness (2004) (13)
- Escalating Immunotherapy with Mitoxantrone in Patients with Very Active Relapsing-Remitting or Progressive Multiple Sclerosis (2000) (13)
- [Heart involvement in progressive external ophthalmoplegia (Kearns-Sayre syndrome): electrophysiologic, hemodynamic and morphologic findings]. (1986) (13)
- Potential implications of a ciliary neurotrophic factor gene mutation in a German population of patients with motor neuron disease. (1998) (13)
- Measles virus‐directed responses of CD4+ T lymphocytes in MS patients and healthy individuals (1993) (13)
- Substance P stimulates release of arachidonic acid cyclooxygenation products from primary culture rat astrocytes (1987) (12)
- Does Down’s Syndrome Protect against Multiple Sclerosis? (2002) (12)
- T lymphocyte recognition sites on peripheral nerve myelin P0 protein (1994) (12)
- T cell antigenic and neuritogenic activity of recombinant human peripheral myelin P2 protein (1995) (12)
- Chronic inflammatory polyneuritis and neuropathies. (1996) (12)
- [The significance of determining antibodies to acetylcholine receptor in myasthenia gravis (author's transl)]. (1979) (12)
- [Recommendations of Bavarian Muscle Centers of the German Neuromuscular Disease Society for home ventilation of neuromuscular diseases of adult patients]. (1997) (11)
- Human T-helper lymphocytes in myasthenia gravis recognize the nicotinic receptor a subunit ( immunoregulation / autoimmune disease / immunotherapy ) (11)
- Mild experimental autoimmune encephalitis as a tool to induce blood–brain barrier dysfunction (2010) (11)
- Involvement of the visual pathway in hereditary neuropathy with liability to pressure palsies (2000) (11)
- Lipooligosaccharide of Campylobacter jejuni prevents myelin-specific enteral tolerance to autoimmune neuritis—a potential mechanism in Guillain-Barré syndrome? (2005) (11)
- The role of dietary non-heme iron load and peripheral nerve inflammation in the development of peripheral neuropathy (PN) in obese non-diabetic leptin-deficient ob/ob mice (2019) (11)
- Multifocal brain MRI hypointensities secondary to embolic metal fragments from a mechanical heart valve prosthesis (1998) (11)
- Necrotizing myopathy in SJL mice. (1988) (11)
- Effector mechanisms in demyelinating neuropathies. (1996) (11)
- Role of TNF-alpha in high-dose antigen therapy in experimental autoimmune neuritis: inhibition of TNF-alpha by neutralizing antibodies reduces T-cell apoptosis and prevents liver necrosis. (2000) (11)
- Usage of vβ3.3 T‐cell receptor by myelin basic protein‐specific encephalitogenic T‐cell lines in the Lewis rat (1999) (11)
- Human monoclonal anti-MAG antibody and anti-Leu 7 recognise shared antigenic determinants in peripheral nerve and spinal cord. (1985) (11)
- Pregnancy and delivery of a healthy baby in autoimmune Lambert-Eaton myasthenic syndrome (2006) (10)
- Chapter 27 – Experimental Autoimmune Neuritis (2005) (10)
- Increased lipocortin-1 (annexin-1) expression in the sciatic nerve of Lewis rats with experimental autoimmune neuritis (1999) (10)
- A comparative trial of anti-glycoconjugate antibody assays: IgM antibodies to GM1 (1994) (10)
- Glucocorticoid-sensitive hereditary inclusion body myositis (1996) (10)
- Analysis of immunoglobulin and T cell receptor gene rearrangements in the thymus of myasthenia gravis patients (1989) (10)
- Distribution, tolerability and tissue compatibility of intrathecal tizanidine in the sheep (1998) (9)
- Role of therapeutic plasmapheresis in chronic inflammatory demyelinating polyneuropathy. (1990) (9)
- Bilateral cerebral emboli monitoring during extracorporeal circulation. (1999) (9)
- Efficacy of Polyvalent Human Immunoglobulins in an Animal Model of Neuromyelitis Optica Evoked by Intrathecal Anti-Aquaporin 4 Antibodies (2016) (9)
- Immune mechanisms in acute and chronic inflammatory polyneuropathies (1988) (9)
- Cerebral Microembolus Generation in Different Extracorporeal Circulation Systems (1999) (9)
- Glucocorticosteroids modulate antigen-induced T cell apoptosis in experimental autoimmune neuritis and cause T cell proliferation in situ (2001) (8)
- [Myotonic dystrophy (DM/Curschmann-Steinert disease) and proximal myotonic myopathy (PROMM/Ricker syndrome). Myotonic muscle diseases with multisystemic manifestations]. (2001) (8)
- Treatment with ciliary neurotrophic factor does not improve regeneration in experimental autoimmune neuritis of the Lewis rat (1996) (8)
- The lateral thoracic nerve and the cutaneous maximus muscle—A novel in vivo model system for nerve degeneration and regeneration studies (2012) (8)
- Soluble dimeric prion protein ligand activates Adgrg6 receptor but does not rescue early signs of demyelination in PrP-deficient mice (2020) (8)
- Ptosis in myasthenia gravis: Extended fatigue and recovery bedside test (2006) (7)
- THE TREATMENT OF MYASTHENIA GRAVIS (1952) (7)
- Myopathy with abnormal mitochondria, transient low electron transport capacity in the respiratory chain, and absence of energy transduction at sites 1 and 2 in vitro. (1986) (7)
- The Gdap 1 knockout mouse mechanistically links redox control to Charcot – Marie – Tooth disease (2014) (7)
- Intravenous immunoglobulin for myasthenia gravis. (2008) (7)
- F response latency determinations. (1984) (7)
- [Follow-up of myasthenia gravis. Results of a longitudinal study of the significance of psychosocial predictors]. (1998) (7)
- Shared T‐cell receptor gene usage in experimental allergic neuritis and encephalomyelitis (1993) (7)
- Nerve conduction abnormalities and neuromyotonia in genetically engineered mouse models of human hereditary neuropathies. (1999) (7)
- Application of the avidin-biotin system for post-embedding cytochemical demonstration of a biotin-labeled IgG tracer. (1986) (7)
- Epstein-Barr virus-transformed B cells can present acetylcholine receptor to autologous autoreactive T cells. (1986) (7)
- Sarcoid myopathy and mitochondrial respiratory chain defects: clinicopathological, biochemical and molecular biological analyses (1995) (7)
- Biomarkers in the diagnosis and therapy of CIDP (2011) (6)
- Oral tolerance in experimental autoimmune neuritis (EAN) of the Lewis rat II. Adjuvant effects and bystander suppression in P2 peptide-induced EAN (2001) (6)
- Oculomotor signs in Lambert‐Eaton myasthenic syndrome—coincidence with myasthenia gravis (2003) (6)
- [Neuromuscular manifestations of HIV-1 and HTLV-I infections]. (2008) (6)
- Myasthenia gravis and Lambert-Eaton Myasthenic Syndrome (1994) (6)
- Myasthenia Gravis: Pathogenesis and Immunotherapy (2007) (6)
- Production and Characterization of Monoclonal Antibodies to the Extracellular Domain of PO (6)
- Effects of polyclonal immunoglobulins and other immunomodulatory agents on microglial phagocytosis of apoptotic inflammatory T-cells (2003) (6)
- Myasthenia gravis: remission not induced by blocking anti-idiotype antibodies. (1983) (6)
- Truncation of the neuritogenic peptide bP2(60–70) results in the generation of altered peptide ligands with the potential to interfere with T cell activation (2002) (6)
- “Sporadic” familial amyloidotic polyneuropathy in a German patient with B cell lymphocytic leukaemia (2002) (6)
- T-cell receptor Vβ-element expression in peripheral nerves of Lewis rats suffering from experimental autoimmune neuritis (1997) (6)
- Plasma-separation in myasthenia gravis: A new method of rapid plasma exchange (1980) (6)
- [Plasma exchange treatment in chronic polyneuritis of the Guillain-Barré type. Experiences with 9 personal cases]. (1986) (6)
- Human T lymphocytes distinguish bovine from human P2 peripheral myelin protein: Implications for immunological studies on inflammatory demyelinating neuropathies (1994) (6)
- Leber´s hereditary optic neuroretinopathy (1993) (5)
- Acute Muscular Weakness (1994) (5)
- Permanent effector phenotype of neuroantigen-specific T cells acquired in the central nervous system during experimental allergic encephalomyelitis (2006) (5)
- [Standardized bicycle ergometry test in mitochondrial myopathies. Indications, interferences and clinical parameters]. (1998) (5)
- [Therapy with immunoglobulins in neurologic autoimmune diseases. Indications and mechanism of action]. (1995) (5)
- Heat hyperalgesia and nociceptor excitation after application of nerve growth factor (NGF) or inflammatory mediators (1996) (5)
- Amyotrophe Lateralsklerose (2010) (5)
- Electrophysiological analysis of cutaneous sensory neurons in neonatal wildtype mice and transgenic animals lacking BDNF (1995) (5)
- Mice carrying an analogous heterozygous dynamin 2 K562E mutation that causes neuropathy in humans develop predominant characteristics of a primary myopathy (2020) (5)
- Nerve Conduction Abnormalities and Neuromyotonia in Genetically Engineered Mouse Models of Human Hereditary Neuropathies (1999) (5)
- Multiple exercise-related mononeuropathy with abdominal colic (1983) (5)
- Novel SOD1 N86K mutation is associated with a severe phenotype in familial ALS (2007) (5)
- Meningioma associated with McCune-Albright syndrome (1999) (5)
- Distal‐symmetric focal inflammatory myopathy distinct from focal myositis and polymyositis (2009) (5)
- Auto-SCT in severe paraproteinemic neuropathy (2011) (4)
- Disorders of Cholinergic Synapses in the Peripheral Nervous System (1988) (4)
- [A transferable "myasthenogenic" factor in the serum of patients with myasthenia gravis (author's transl)]. (1976) (4)
- Treatment-Induced Neuropathy in Diabetes (TIND)—Developing a Disease Model in Type 1 Diabetic Rats (2021) (4)
- Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic (2010) (4)
- [Cyclophosphamide in therapy of chronic progressive multiple sclerosis. Critical analysis of current studies]. (1994) (4)
- New concepts in immunotherapy. (1984) (4)
- sICAM-1 is not a marker for disease activity in the relapse-free interval of multiple sclerosis - a cross-sectional pilot study (2002) (4)
- Ciliary neurotrophic factor (CNTF): physiological and pharmacological effects. (1995) (3)
- Persisting rhinorrhoea and headache as the initial symptom of bilateral carotid artery dissection (1999) (3)
- Postlumbar puncture headache. (1997) (3)
- [Recurrent transverse myelitis. 2 cases and review of the literature]. (1998) (3)
- Synergism in the pathogenesis of EAE induced by an MBP-specific T cell line and monoclonal antibodies to Galacto-Cerebroside or to a myelin oligodendroglial glycoprotein (1987) (3)
- [Clenbuterol in amyotrophic lateral sclerosis. No indication for a positive effect]. (1999) (3)
- [Mitoxantrone (Novantron) in therapy of severe multiple sclerosis. A retrospective study of 15 patients]. (1999) (3)
- Quantitative magnetization transfer imaging in human brain by means of a PACE technique. (1999) (3)
- B cell responses to the PNS protein P0 in experimental autoimmune neuritis (1995) (3)
- Quantitative analysis of energy metabolism in human muscle using SLOOP 31P-MR-spectroscopy. (2002) (3)
- Myasthenia gravis: Current State of Knowledge (1981) (3)
- α‐Fetoprotein and neonatal transient myasthenia gravis (1984) (3)
- Plasmapheresis in chronic demyelinating polyneuropathy. (1992) (3)
- Autoimmunity in the peripheral nervous system. (1996) (2)
- Sequestration of endogenous NGF in adult rats specifically reduces the sensitivity of nociceptors to heat and bradykinin (1996) (2)
- [Immunogenetics of myasthenia gravis]. (1983) (2)
- Activation of dissociated IB4 binding dorsal root ganglion (DRG) neurons by ATP and capsaicin (CAPS) (1998) (2)
- Oxide Synthase Th 1-Type Cytokines and Inducible Nitric Encephalomyelitis : Rapid Induction of Therapy in Experimental Autoimmune Molecular Mechanisms of High-Dose Antigen (2000) (2)
- The effect of noradrenaline on the receptive properties of cutaneous C-fibres in a chronic constriction neuropathy (1993) (2)
- Treatment with recombinant human nerve growth factor (rhNGF) normalises the small fibre neuropathy in STZ diabetic rats (1996) (2)
- [New aspects of the pathogenesis and therapy of Guillain-Barré syndrome and chronic polyneuritis]. (1990) (2)
- Cardiac Involvement in Kearns-Sayre Syndrome (1989) (2)
- Current status of plasma exchange in Neurology (1988) (2)
- Chapter 25 – Introduction to Immune Reactions in the Peripheral Nervous System (2005) (2)
- Intravenous immunoglobulin for myasthenia gravis. (2006) (2)
- [Amyotrophic lateral sclerosis: management of bulbar symptoms]. (2010) (2)
- alpha-Fetoprotein and neonatal transient myasthenia gravis. (1984) (2)
- Persisting rhinorrhea and headache as the initial symptom of bilateral carotid artery dissection. (1999) (2)
- The 3rd German-Japanese Joint Workshop. Cell Death in the CNS: Molecules and Programs (1996) (2)
- BONE MARROW TRANSFER FROM WILD‐TYPE MICE REVERTS THE BENEFICIAL EFFECT OF GENETICALLY MEDIATED IMMUNE DEFICIENCY IN MYELIN MUTANTS (2002) (2)
- [Multiple sclerosis: updates on pathogenesis and treatment: report from the 9th MS Symposium held by the German Multiple Sclerosis Society]. (2011) (2)
- Myeloma neuropathy: Clinical and electrophysiological monitoring under plasma exchange therapy (1983) (2)
- Can we get rid of neutralizing antibodies against interferon‐β? (2009) (2)
- [Comment on the contribution by F. Zipp and K. P. Wandinger. Current recommendations for vaccinations in multiple sclerosis]. (2001) (1)
- Dimeric prion protein ligand activates Adgrg6 but does not rescue myelinopathy of PrP-deficient mice (2020) (1)
- Analysis of cutaneous afferents in mice carrying targeted mutations of the BDNF gene (1996) (1)
- Immune mechanisms in neurological disease (2002) (1)
- T-cell receptor V beta-element expression in peripheral nerves of Lewis rats suffering from experimental autoimmune neuritis. (1997) (1)
- Modulation of EAE by vaccination with T cell receptor peptides: V beta 8 T cell receptor peptide-specific CD4+ lack direct immunoregulatory activity. (1994) (1)
- Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain (1994) (1)
- Functional properties of cutaneous unmyelinated afferents in a chronic constriction neuropathy (1993) (1)
- Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain (1994) (1)
- Focal brain ischemia in mice does not cause electrophysiological signs of critical illness neuropathy (2020) (1)
- Differences in Antigen Expression on Normal Thymocytes and on Cells Derived from Hyperplastic Thymi and Thymoma of Myasthenia Gravis Patients (1984) (1)
- Kenneth Ricker, MD (1935–2004) (2004) (1)
- Augmentation of oxidative and arachidonate metabolism in macrophages by tuftsin (Thr-Lys-Pro-Arg) (1984) (1)
- Analysis of mice carrying targeted mutations of the BDNF gene (1994) (1)
- Immune Deficiency in Mouse Models for Inherited Peripheral Neuropathies Leads to Improved Myelin Maintenance (2000) (1)
- Bacterial expression of a soluble T-cell receptor alpha chain. (1994) (1)
- GUILLAIN-BARRÉSYNDROME: PROGNOSIS AND PATHOGENESIS (1988) (1)
- Pierson syndrome (2020) (1)
- Serum acetylcholine receptor antibodies in diagnosis and therapy monitoring of myasthenia gravis (1980) (1)
- 4-13-14 Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen species (1997) (1)
- [Autoimmune neuropathies--current aspects of immunopathologic diagnostics and therapy]. (2005) (1)
- [Active vaccinations in multiple sclerosis]. (1995) (1)
- [Hydranencephaly versus spelencephaly--a report of two cases (author's transl)]. (1977) (1)
- [Muscle biopsy in progressive external ophthalmoplegia (author's transl)]. (1979) (1)
- Disease Management in Multiple Sclerosis (2005) (1)
- Inclusion body myositis in twins [6] (multiple letters) (1999) (1)
- The immune system in neurologic disease: selected recent developments. (1996) (1)
- A practicable method for the analysis of T lymphocyte subsets in CSF lymphopleocytosis (1983) (1)
- Clinical implementation of anti-acetylcholine receptor antibodies. (1994) (1)
- Adoptive transfer experimental autoimmune encephalitis: evidence for central and peripheral nerve dysfunction (1987) (1)
- Humoral or cellular effector mechanisms? (1983) (1)
- [Home ventilation in neuromuscular diseases in adults. Presentation of recommendations of the Bavarian Muscle Centers of the DGM]. (1996) (1)
- [Immune augmenting therapy as treatment of multiple sclerosis. Warning regarding a potentially toxic alternative treatment method]. (1994) (1)
- Long-Term Prognosis of Patients with Thymoma-Associated Myasthenia Gravis (1997) (1)
- Myasthenia gravis: new therapeutic strategies. (1988) (1)
- Significance of acetylcholine receptor antibody in the diagnosis and therapy monitoring ofMy Asthenia gravis (1980) (1)
- Contents Vol. 53, 2005 (2005) (1)
- Lambert-Eaton myasthenic syndrome: evaluation of movement performance following drug therapy. (1994) (1)
- Letters to the editor (1991) (1)
- PROTECTION OF END PLATES BY FAB FRAGMENTS FROM HUMAN MYASTHENIC IGG IN THE MOUSE TRANSFER MODEL (1981) (1)
- Complex immunoregulatory events during pregnancy may explain reduced relapse rate in multiple sclerosis (1998) (1)
- 154 Specific subtypes of cutaneous mechanoreceptors require neurotrophin-3 following peripheral target innervation (1996) (1)
- [Treatment of relapsing-remitting multiple sclerosis with recombinant interferon-beta preparations]. (2001) (1)
- Soluble VCAM-1 Release Indicates Inflammatory Blood-Brain Barrier Pathology and Further Modulates Adhesion (2004) (1)
- [New aspects in the diagnosis of herpes simplex virus encephalitis--case reports and virologic findings]. (1992) (0)
- 11th meeting of the peripheral nerve study group (PNSG) “lostergut Jakobsberg”, Boppard, Germany 29 July–1 August 1993 (1995) (0)
- [Paraneoplastic syndromes of the nervous system]. (1990) (0)
- Peripheral neuropathy orchestrated by nonneural-specific lymphocytes (1994) (0)
- [The role of the immune system in hereditary demyelinating neuropathies]. (2005) (0)
- Efficacy of therapy in juvenile myasthenia gravis (M.G.) (1991) (0)
- [Alopecia areata and EEG-changes]. (1974) (0)
- Author response: Defective synaptic transmission causes disease signs in a mouse model of juvenile neuronal ceroid lipofuscinosis (2017) (0)
- DRUG TARGETING BY LONG-CIRCULATING LIPOSOMAL GLUCOCORTICOIDS INCREASES THERAPEUTIC EFFICACY IN A MODEL OF MULTIPLE SCLEROSIS CHAPTER (2003) (0)
- Reactive nitrogen intermediates: Effector molecules of immune‐mediated inflammatory nervous system disorders? (1993) (0)
- 5-25-07 T cell activation and homing in adoptive transfer experimental autoimmune neuritis (AT-EAN) (1997) (0)
- Subject Index Vol. 53, 2005 (2005) (0)
- Role of autophagy in adipose tissue and in peripheral nervous system in diabetes type 2, obesity and metabolic syndrome (2016) (0)
- Immune-mediated peripheral nerve disorders (1991) (0)
- Letters to the Editor (1988) (0)
- Book Review / Announcement (2002) (0)
- [Periarticular ossification following severe brain injury]. (1977) (0)
- [A transferable "Myasthenogenic" factor in the serum of patients with myasthenia gravis.]. (1976) (0)
- 5-29-10 Mitochondrial dysfunction with MERRF point-mutation in nerve and muscle tissue of a patient with multiple symmetric lipomatosis (1997) (0)
- Anti-nicotinic receptor autoimmunity in myasthenia gravis. Establishment of specific T-helper cell lines and identification of sensitizing epitopes on the alpha-subunit. (1988) (0)
- Effective Treatment With Intracutaneous Botulinum Toxin (2017) (0)
- This information is current as Encephalomyelitis of SJL Mice Experimental Autoimmune 151 Peptide-Induced - Protein 139 IL-17-Producing CD4 Cells in Proteolipid Kinetics and Organ Distribution of (2017) (0)
- Author response: Schwann cells, but not Oligodendrocytes, Depend Strictly on Dynamin 2 Function (2018) (0)
- Aetiology of small-and mixed-fiber neuropathy (2006) (0)
- Tor1a+/- mice develop dystonia-like movements via a striatal dopaminergic dysregulation triggered by peripheral nerve injury (2016) (0)
- Book reviews – Announcements (2001) (0)
- In Memoriam: Daniel B. Drachman (2022) (0)
- MRI changes of nerve and muscle after nerve lesions: Correlation with electromyography and histology (2005) (0)
- Stimulation of autoimmune helper T-lymphocytes from myasthenia gravis patients with synthetic peptides of the acetylcholine receptor alpha subunit (1987) (0)
- Fisher syndrome : immunofluorescence and immunoelectron microscopic localization of IgG at the mouse neuromuscular junction (0)
- Encephalomyelitis of SJL Mice Experimental Autoimmune 151 Peptide-Induced − Protein 139 IL-17-Producing CD 4 Cells in Proteolipid Kinetics and Organ Distribution of Tary-Lehmann and (2007) (0)
- T cell receptor Vβ sequence analysis in target tissue suggests contribution of myelin basic protein autoreactivity to experimental allergic neuritis (1994) (0)
- [Clinical, morphological and biochemical findings in the Kearns-Sayre syndrome]. (1983) (0)
- Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, and Axonal Degeneration and Regeneration (2008) (0)
- Reversible, combined pre- and postsynaptic blockade of neuromuscular transmission by anti-GQ1b antibodies from patients with Miller Fisher syndrome (MFS) (1999) (0)
- Expression of P0 Tolerance Induction by Intrathymic (2004) (0)
- [Disorders of receptor function as a pathogenetic principle in myasthenia gravis]. (1988) (0)
- Localization of Interferon-y and la-Antigen in T Cell Line-Mediated Experimental Autoimmune Encephalomyelitis (2007) (0)
- Letters to the editor (1983) (0)
- Communications of the European Neurological Society (2001) (0)
- Some Thoughts from Your Publisher (2002) (0)
- Different monoclonal anti-ganglioside antibodies show distinct effects on presynaptic transmitter release and calcium influx (2006) (0)
- ENS News (1999) (0)
- 19Syndrome, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, and Axonal Degeneration and Regeneration (2008) (0)
- [Therapy of acute polyradiculoneuritis (Guillain-Barré syndrome)]. (1994) (0)
- [Early diagnosis of multiple sclerosis]. (2000) (0)
- T-cell apoptosis in the nervous system and therapeutic implications (2001) (0)
- Letters to the editor (0)
- Myasthene Krise (2003) (0)
- Morphological And Electrophysiological Signs Of Dysmyelination In Transgenic Mice Expressing CMT1B (MPZ DELSer34) or DSS (MPZ Ser34Cys) Mutations (2001) (0)
- Selective Adsorption Therapy in Myasthenia Gravis (1987) (0)
- Surgical and neurological outcome of thymectomy for myasthenia gravis (2008) (0)
- Neurofibromatous neuropathy. (1991) (0)
- A reliable method for immunocytochemical characterization of CSF cells (1987) (0)
- Sequence and diversity of rat T-cell receptor Tcra V8 gene segments (2004) (0)
- Functional predictors of treatment induced diabetic neuropathy (TIND): a prospective pilot study using clinical and neurophysiological functional tests (2021) (0)
- Eleventh meeting of The European Neurological Society21–25 April, 2001, Paris, France (2001) (0)
- Correction: Effects of Natalizumab Treatment on Foxp3+ T Regulatory Cells (2010) (0)
- [Distrubances in glucose metabolism during diphenyhydantoin treatment in childhood]. (1975) (0)
- Abstracts Second Congress of the European Society for Clinical Neuropharmacology (1995) (0)
- Suppression of P2-T cell-line mediated experimental autoimmune neuritis by interleukin 2 — Receptor blockade (1987) (0)
- Myasthenia gravis : First European Conference on Myasthenia Gravis, Maastricht, June 15-16, 1987 (1988) (0)
- Changes of the Blood-Nerve Barrier During Nerve Regeneration in the Mouse (1987) (0)
- The thymic remnant in the pathogenesis of thymoma associated myasthenia gravis (MG) (1991) (0)
- Surgical outcome and survival after thymomectomy (2008) (0)
- Mitochondrial dysfunction with MERRF point-mutation in nerve and mucle tissue of a patient with multiple symmetric lipomatosis (1997) (0)
- 3-24-08 Apoptotic cell death of myoblasts by oxidative stress and nitric oxide (1997) (0)
- Immunohistochemical Demonstration of IgG and Fab Fragments at Motor Endplates of Passively Transferred Mice (1981) (0)
- Letters to the editor (1984) (0)
- Administration of nitric oxide (NO) synthase inhibitors in experimental autoimmune encephalomyelitis (EAE) (1995) (0)
- IMMUNOGLOBULIN G FROM PATIENTS WITH CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) AFFECTS PRESYNAPTIC TRANSMITTER RELEASE AND CALCIUM INFLUX (2009) (0)
- Abstracts of the Symposia (2006) (0)
- Hydrophobic binding properties of AChR-antibodies: aspects for therapy and pathomechanism in myasthenia gravis (1989) (0)
- Cellular immunity in inflammatory autoimmune neuropathies. (2002) (0)
- Suppression and Treatment of EAN by Novel Antiinflammatory Agents Acting on Macrophages (1987) (0)
- Effect of Intravenous Diphenylhydantoin on Glucose Tolerance and Insulin Response in Children (1975) (0)
- Peripheral Nerve Study Group, in Boppard, Germany, July 29th to August 1, 1993. (1994) (0)
- Quantitative magnetization transfer imaging in relapsing multiple sclerosis. (2000) (0)
- [Retinal dystrophy in mitochondriopathy]. (1986) (0)
- [Analysis of surface markers on cerebrospinal fluid-producing cells. Contribution to the differential diagnosis of intrathecal lymphomas]. (1984) (0)
- Cancer Incidence in 677 Mitoxantrone-Treated People with Multiple Sclerosis: A Retrospective German Single Center Cohort Study (P01.175) (2013) (0)
- Antibodies against the amphiphysin sh-3 domain mediate reduced gabaergic motor inhibition and anxiety of stiff person syndrome (2008) (0)
- Professor Georg Becker, MD (1961–2003) (2003) (0)
- Focal brain ischemia in mice does not cause electrophysiological signs of critical illness neuropathy (2020) (0)
- [Successful treatment of multiple sclerosis with beta-interferon]. (1999) (0)
- Postnatal survival of Merkel cells depends on the low affinity neurotrophin receptor p75. (1998) (0)
- Analysis of sensory neurons in transgenic mice carrying targeted mutations of the p75 gene (1996) (0)
- Single unit recordings from chick cutaneous sensory neurons in vitro (1994) (0)
- Temporary reversal of nerve and muscle dysfunction by serial electrical stimulation in critical illness neuromyopathy (2022) (0)
- Oral session 39 — Growth factors (2005) (0)
- Severely decreased skin innervation in mice lacking the low affinity neurotrophin receptor (1996) (0)
- Excitability decreasing central motor plasticity and functional role of primary motor cortex are retained in multiple sclerosis patients (2012) (0)
- Abnormal functional properties of nociceptive afferents in neuropathic pain (1993) (0)
- Effects of BDNF and NGF on cytokine expression in immune cells (2001) (0)
- Targeted rescue of synaptic plasticity improves cognitive decline after severe systemic inflammation (2021) (0)
- Interferon-b induces release of soluble adhesion molecules from human cerebral endothelial cells (1998) (0)
- Effect of tetrodotoxin on cutaneous afferent fibers in adult rat in the skin-nerve in vitro preparation (1996) (0)
- Short-term plasticity is not compromised in multiple sclerosis patients (2008) (0)
- Characterization of cutaneous sensory neurones in BDNF transgenic animals (1995) (0)
- Nerve growth factor (NGF) is required for the function of unmyelinated nociceptive afferents (1995) (0)
- NGF produces heat hyperalgesia, an excitation of nociceptors and sensitization to heat (1996) (0)
- [Therapy of MS symptoms. Here also are guidelines necessary]. (2004) (0)
- [Oral, low-dosage methotrexate in chronic progressive multiple sclerosis. A preliminary critical analysis]. (1995) (0)
- Plasma exchange for generalised myasthenia gravis (Review) (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Klaus Viktor Toyka?
Klaus Viktor Toyka is affiliated with the following schools: